News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Assenagon Asset Management S.A. recently acquired 45,236 shares of AMN Healthcare Services Inc. (NYSE:AMN) valued at approximately $1.46 million, making them one of many institutional investors who collectively own 99.23% of the company. AMN Healthcare reported strong quarterly earnings, beating analyst estimates for both …
Whitefort Capital Management, along with David Salanic and Joseph Kaplan, has reported a beneficial ownership of 7.1% in OmniAb, Inc. (OABI) through an amended Schedule 13G filing. This group beneficially owns 10,248,658 shares, representing 7.1% of OmniAb's outstanding shares as of June 30, 2026. …
Amneal Pharmaceuticals director John Kiely reported selling 50,000 shares of Class A Common Stock at a weighted average price of $17.64 per share on August 13, 2026. Additionally, he made a charitable donation of 10,000 shares of Class A Common Stock to a donor-advised …
John Kiely, a director at Amneal Pharmaceuticals (NASDAQ: AMRX), sold 50,000 shares of Class A Common Stock at an average price of $17.64 and donated 10,000 shares to a donor-advised fund on August 13, 2026. After these transactions, Kiely's direct ownership in the company …
CorMedix Therapeutics CRMD delivered second-quarter 2026 adjusted earnings of 29 cents per share, which increased 4% year over year from 28 cents reported in the year-ago quarter. The reported figure beat the Zacks Consensus Estimate of 26 cents. Consolidated revenues were $101.9 million, which …
Vuzix Corporation Q2 2026 Earnings Call Summary - Moby Strategic Drivers and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …
OmniAb (OABI) reported strong Q2 2026 financial results, with revenue reaching $13.4 million, primarily driven by milestone achievements from clinical program advancements. The company raised its full-year 2026 revenue guidance to $32 million to $36 million and expects to end the year with $37 …
Vuzix reported a 14% revenue decline in Q2 2026 to $1.1 million but highlighted expanding opportunities in enterprise smart glasses, OEM programs, and waveguide technology, driven by AI. The company is focusing on these three growth pillars, with CEO Paul Travers noting increased interest …
Dimensional Fund Advisors LP significantly reduced its stake in OmniAb, Inc. by 18.9% in the first quarter, although it still holds 1.75 million shares valued at $2.74 million. OmniAb exceeded analyst expectations with its recent earnings report, posting a smaller-than-expected loss and higher revenue, …
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Randle ReecePresident and Chief Executive Officer - Caroline GraceChief Financial and Operating Officer - Brian Scott TAKEAWAYS Revenue -- $673 million, representing …
Vuzix Corporation reported a 14 percent decrease in total revenues for Q2 2026, totaling $1.1 million, but highlighted strategic investments in its waveguide plant and increased engagement in the smart glasses ecosystem. The company sees significant opportunities in AI-powered enterprise smart glasses, citing recent …
Amneal Pharmaceuticals director Kevin J. Buchi reported a derivative exercise/conversion transaction involving 168,573 shares of Class A Common Stock on August 11, 2026. The shares were sold at a weighted average price of $17.18, with individual trades ranging from $17.07 to $17.31. Following this …
Omnicom Group Inc (OMC) shares recently rose 3.3% to $88.36, trading near its 52-week high, with a GF Value of $93.75 suggesting it is undervalued by 5.7%. The company has a strong GF Score of 86/100, indicating good profitability, growth, and appealing valuation, though …
Vuzix Corp. reported a mixed second quarter for 2026, with revenue of $1.1 million falling significantly short of analyst forecasts, leading to a 7.2% drop in after-hours trading. Despite beating EPS estimates, the company's sales declined 14% year-over-year, mainly due to decreased M400 smart …
Amneal Pharmaceuticals' EVP and Chief Legal Officer, Jason B. Daly, sold a total of 216,613 shares of Class A Common Stock in two separate transactions on August 11 and August 12, 2026. The sales were open-market transactions, not pursuant to a Rule 10b5-1 trading …
VUZIX ($VUZI) reported its Q2 2026 earnings, posting a loss of -$0.09 per share, which beat analyst estimates by $0.02. However, the company's revenue of $1,110,000 missed expectations by over $422,000, leading to a 7.98% stock price decline since market close. The article also …
Morgan Stanley has disclosed a 5.4% passive ownership stake in AMN Healthcare Services, Inc., amounting to 2,076,006 shares of common stock as of June 30, 2026. The filing, a Schedule 13G, indicates that Morgan Stanley has shared voting power over 2,075,030 shares and shared …
This article is a placeholder for Vuzix's Q2 earnings snapshot. It currently contains no specific financial details or further information beyond its title, suggesting the full report has not yet been published or made available.
Vuzix Corp Cmn Stk (NASDAQ: VUZI) reported second-quarter EPS of $-0.090, beating analyst estimates by $0.01. However, the company's revenue of $1.11M fell short of the consensus estimate of $2.49M. The stock has seen a -12.330% decrease in the last three months but is …
Vuzix Corporation announced its financial results for the second quarter and six months ended June 30, 2026. For the second quarter, revenue decreased to USD 1.11 million from USD 1.3 million year-over-year, while net loss remained stable at USD 7.63 million. The company reported …
Omnicom Group Inc. (OMC) stock advanced 3.33% to $88.36 on Thursday, despite underperforming compared to some competitors. The company reached a new 52-week high, surpassing its previous peak of $87.41. This occurred during a favorable trading session where the S&P 500 Index and Dow …
Omnicell (OMCL) has raised its 2026 earnings outlook after a strong second quarter, though a significant portion of the profit improvement came from a one-time tariff refund. The company faces increased memory-chip costs expected to impact gross margins but plans to leverage cost control …
This article highlights bullish sentiments from analysts for three NA sector companies: Enhanced Group (ENHA), MNTN, Inc Class A (MNTN), and Bicara Therapeutics Inc. (BCAX). Enhanced Group received a "Moderate Buy" consensus with a $6.00 price target, MNTN, Inc Class A earned a "Strong …
This article provides an analysis and prediction of OABI's earnings, focusing on past results, analyst forecasts for 2026/Q3, and the correlation between earning revisions and stock price movements. It details OABI's recent earnings reports, including revenue and EPS surprises, and discusses the typical stock …
Sei Investments Co. significantly increased its stake in AMN Healthcare Services Inc. (NYSE:AMN) by 204.7% in the first quarter, purchasing an additional 34,925 shares. This move is part of a broader trend of institutional investors adjusting their positions in AMN Healthcare, with several firms …
AMN Healthcare Services reported Q2 results that surpassed analyst expectations, driven by strong demand in its Nurse and Allied Solutions segment and effective execution. The article highlights five key analyst questions from the earnings call, covering topics like contingent labor trends, margin assumptions, bill …
Search by ticker symbol or company name and select a result to open its chart.